A case of successful contribution of therapeutic drug monitoring of valganciclovir as the prophylaxis against cytomegalovirus infection in a lung transplant recipient

• প্রধান লেখক: Yoshiki Katada (লেখক), Keisuke Umemura (লেখক), Shunsaku Nakagawa (লেখক), Yurie Katsube (লেখক), Masahiro Tsuda (লেখক), Satona Tanaka (লেখক), Hiroshi Date (লেখক), Miki Nagao (লেখক), Tomohiro Terada (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BMC, 2024-06-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Background Ganciclovir and its prodrug, valganciclovir, are first-line agents for cytomegalovirus infection prophylaxis after lung transplantation. Although valganciclovir prophylaxis is known to result in severe leukopenia as an adverse effect, dosage adjustment based on therapeutic drug m...